ORAMED PHARMACEUTICALS INC. (ORMP) › Shareholders' EquityORAMED PHARMACEUTICALS INC. (ORMP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2002: $53.7K2007: $513.1K2008: $4.59M2009: $2.75M2010: $830.3K2011: $3.72M2012: $3.78M2013: $8.13M2014: $20.79M2015: $24.83M2016: $26.19M2017: $19.24M2018: $31.11M2019: $19.39M2020: $32.88M2021: $166.45M2022: $151.81M2023: $163.82M2024: $146.26M2025: $199.74M$199.74M2002Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$199.74M+36.6%2024$146.26M-10.7%2023$163.82M+7.9%2022$151.81M-8.8%2021$166.45M+406.3%2020$32.88M+69.5%2019$19.39M-37.7%2018$31.11M+61.7%2017$19.24M-26.5%2016$26.19M+5.5%2015$24.83M+19.4%2014$20.79M+155.7%2013$8.13M+115.2%2012$3.78M+1.5%2011$3.72M+348.4%2010$830.3K-69.8%2009$2.75M-40.2%2008$4.59M+795.1%2007$513.1K—2002$53.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share